Search for: "Mylan Pharmaceuticals"
Results 441 - 460
of 739
Sort by Relevance
|
Sort by Date
23 Aug 2011, 7:27 am
Mylan, Inc., 2011 U.S. [read post]
10 Aug 2011, 8:59 am
Mylan Pharmaceuticals Inc., C.A. [read post]
9 Aug 2011, 9:50 am
Mylan Pharmaceuticals, Inc., 696 F.Supp.2d 599 (N.D.W. [read post]
6 Aug 2011, 2:27 pm
Bodily Injury: COURT FINDS NO BODILY INJURY IN DEAD-BODIES CASE, Owners Ins. [read post]
5 Aug 2011, 12:29 pm
., Mylan, Inc., Teva Pharmaceutical Industries, and UDL Laboratories, Inc. [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Holman’s Biotech IP Blog) US: Myriad writes to CAFC on standing issue (Patent Docs) (Patent Docs) (Holman’s Biotech IP Blog) US: In the first 7 months of 2011, the FDA has approved 18 new molecular entity pharmaceutical drugs (and no biologic NMEs) (KEI) US: Embryonic stem cell funding suit dead: Sherley v. [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
27 Jul 2011, 4:06 pm
Caraco :Defendants-Appellees Caraco Pharmaceutical Labora- tories, Ltd. and Sun Pharmaceutical Industries, Ltd. [read post]
27 Jul 2011, 1:01 am
KG (TTABlog) US: ALJ Rogers sets 17-month target date in Certain Coenzyme Q10 Products (337-TA-790) (ITC 337 Law Blog) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaints against APP Pharmaceuticals in Delaware and S D Indiana in response to Para IV certification filing (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of… [read post]
25 Jul 2011, 1:34 am
Mylan Inc. and Momenta Pharmaceuticals Inc. have each challenged Teva's patents on Copaxone.Separately, note the postGeneric drugs have slower approval route than new ones, backlogged by FDA staff shortage [read post]
21 Jul 2011, 7:33 am
Mylan Pharmaceuticals Inc. et al, a wrongful death lawsuit brought by Randy Mace of North Carolina against Mylan, a company headquartered in West Virginia. [read post]
20 Jul 2011, 4:04 am
– Economic Times reports ‘Letter of Understanding’ between EU and India (Spicy IP) (Generic Pharmaceuticals and IP) France considers paralysing IP rights on the appearance of generic drugs (Class 46) India: Application of Orphan Drug Act to section 3(d)? [read post]
18 Jul 2011, 8:21 am
Mylan, Takeda v. [read post]
18 Jul 2011, 8:21 am
Mylan, Takeda v. [read post]
13 Jul 2011, 3:04 am
(The SPC Blog) Doha+10: On November 14, 2011, a meeting at WIPO in Geneva to discuss the Doha Declaration (KEI) Docs at BIO: Session on IP challenges for personalised medicine (Patent Docs) France to reform its pharmaceutical regulatory system… with possible global implications! [read post]
6 Jul 2011, 2:21 am
(2) (PatLit) Lidoderm (Lidocaine) – US: Delaware District Court decision in Endo Pharmaceuticals patent case favors Watson (GenericsWeb) Lidoderm (Lidocaine) – US: Endo files patent infringement suit against Watson in response to Para IV challenge (Patent Docs) Lipitor (Atorvastatin) – UK: English Patent Court grants temporary restraining order against Teva on short notice – Pfizer threatens pharmacies with legal action over generic Atorvastatin supply (Kluwer Patent… [read post]
1 Jul 2011, 8:06 am
Mylan Pharmaceuticals, Inc., C.A. [read post]
30 Jun 2011, 2:13 pm
Patent No. 7,915,307...This action relates to an Abbreviated New Drug Application ("ANDA") filed by Mylan Pharmaceuticals, Inc. with the U.S. [read post]
29 Jun 2011, 3:34 am
Sagent Pharmaceuticals, Inc. et al. [read post]
27 Jun 2011, 8:41 am
Amicus brief of Mylan Pharmaceuticals, Inc. [read post]
